NCT03257150 A Study of the Use of Irreversible Electroporation in Pancreatic Ductal Cancer Status COMPLETED Phase NA
NCT03012282 CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer Status TERMINATED Phase NA
NCT02981342 A Study of Abemaciclib (LY2835219) Alone or in Combination With Other Agents in Participants With Previously Treated Pancreatic Ductal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT02959164 Decitabine and Gemcitabine for Pancreatic Cancer and Sarcoma Status COMPLETED Phase PHASE1
NCT02929797 Immunotherapy of CD8+NKG2D+ AKT Cell With Chemotherapy to Pancreatic Cancer Status UNKNOWN Phase EARLY_PHASE1
NCT02790944 Utilizing a Multi-gene Testing Approach to Identify Hereditary Pancreatic Cancer Status COMPLETED Phase N/A
NCT02787187 Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended? Status COMPLETED Phase NA
NCT02757859 High Volume Washing of the Abdomen in Increasing Survival After Surgery in Patients With Pancreatic Cancer That Can Be Removed by Surgery Status RECRUITING Phase NA
NCT02677038 Olaparib in Treating Patients With Stage IV Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT02607826 Short-term Starvation vs. Normal Diet Before Chemotherapy of Solid Tumors Status UNKNOWN Phase NA
NCT02575508 Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT02570529 Prevention of Upper Gastrointestinal Hemorrhage Using Albis® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy Status WITHDRAWN Phase PHASE4
NCT02527434 Study of Tremelimumab in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE2
NCT02498613 A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02440958 Modified FOLFIRINOX for Gemcitabine Refractory Pancreatic Cancer: A Phase II Multicenter Trial Status COMPLETED Phase PHASE2